El Hospital de Sabadell, también conocido como Hospital Taulí u Hospital Parc Taulí, es el principal hospital de la ciudad de Sabadell. Se encuentra en el parque Taulí, en la parte nordeste de la ciudad, conocida como el Taulí.​

During the past decade, Corporacio Sanitaria Parc Tauli; Servicio de Oncologia conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 20 clinical trials were completed, i.e. on average, 87% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are "Breast Cancer" (8 trials), "Breast Neoplasms" (3 trials), "Ovarian Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Urothelial Carcinoma" (2 trials). Many other conditions were trialed in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are "Drug" (33 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (14 trials), "Carboplatin" (9 trials), "Placebo" (9 trials), "Paclitaxel" (8 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" are 26 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".